This is plausible since preeclampsia patients have increased circulating levels of tumor necrosis factor alpha (TNFα) [20], interleukin (IL)-2 [37,38], IL-6 [21], and IL-17 [39,40,41]. This evidence concerns the gene IL17A and preeclampsia.